期刊文献+

急诊肺炎与抗生素合理应用的临床研究

Clinic Observation on Emergence Patients with Pulmonary Infection and Antibiotic Therapy
在线阅读 下载PDF
导出
摘要 目的:了解急诊肺炎的病原体分布、药敏试验、抗生素的使用以及影响预后因素。方法:对本急救中心2001年11月-2003年10月收治的70例急诊肺炎的临床特点、病原学资料、治疗和转归进行回顾性分析。结果:(1)单一肺炎诊断16例、合并有基础疾病或并发症54例;(2)检出病原体中细菌占90.8%:其中G-杆菌占59.8%、G+球菌占31.0%,真菌占9.2%;(3)有效率89%、死亡率11%。结论:革兰氏阴性杆菌是急诊肺炎主要的致病菌,对传统第一线抗生素多耐药,大多对合成抗生素和广谱抗生素较敏感;影响急诊肺炎预后的主要因素是延误就诊时间、抵抗力下降、院外抗生素滥用、敏感菌株减少以及基础疾病严重程度。 Objective:To understand pathogen distribution and the sensitivity to antibiotic therapy and the factors effecting. Methods:70 patients with pulmonary infection at the emergency centre from 2001.11 to 2003.10 were retrospectively analyzed. Result: (1)16 cases of only pulmonary diagnose, 54 cases of underlying disease; (2)90.8% of bacteria in pathogen though examination, in which 59.8% gram-negative bacteria, 31.0% gram-positive bacteria,9.2% fungi; (3)effective rate was 89%,death rate was 11.9%. Conclusions: It revealed that the pathogen of patients was dominated by gram-negative bacteria. Antibiotic sensitivity test showed that the resistance of pathogen to traditional first antibiotics was increased. Synthetic and broad-spectrum antibiotics were more sensitive. The prognosis main factor of affecting emergence pulmonary infection is the delay of treatment, the decline of resistance, the misuse of community antibiotics, the decrease of bacteria sensitivity and the seriousness of underlying disease.
出处 《岭南急诊医学杂志》 2004年第3期172-173,共2页 Lingnan Journal of Emergency Medicine
关键词 肺炎 急诊 抗生素 基础疾病 并发症 合理应用 诊断 合并 pulmonary infection pathogen antibiotic
  • 相关文献

参考文献4

二级参考文献37

  • 1Bartlett JG,Breiman RF,Mandell LA,et al. Community-acquired pneumonia in adults:guidelines for management.The Infectious Diseases Society of America. Clin Infect Dis,1998 ,26:811-838.
  • 2Lim WS,Macfarlane JT,Boswell TC,et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax,2001,56:296-301.
  • 3Gomez J,Banos V,Ruiz Gomez J,et al. Prospective study of epidemiology and prognostic factors in community-acquired pneumonia. Eur J Clin Microbiol Infec Dis,1996,15:556-560.
  • 4Torres A,El Ebiary M,Riquelme R,et al. Community-acquired pneumonia in the elderly. Semin Respir Infect,1999,14:173-183.
  • 5Higuera F,Hidalgo H,Feris J,et al. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia. J Antimicrob Chemother,1996 ,37:555-564.
  • 6Bollowa JGM. The reliability of sputum typing and its relation to serum therapy. JAMA,1935,105:1512-1518.
  • 7Bartlett JG,Mundy LM.Community-acquired pneumonia.N Engl J Med,1995,333:1618-1624.
  • 8Lieberman D,Schlaeffer F,Boldur I,et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorox,1996 ,51:179-184.
  • 9Ruiz-Gonzalez A,Falguera M,Nogues A,et al. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology?A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med,1999,106:385-390.
  • 10Kauppinen MT,Herva E,Kujala P,et al.The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis,1995 ,172:1330-1335.

共引文献1103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部